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ABSTRACT 
Background: Generalised Anxiety Disorder (GAD) and Panic Disorder (PD) differ in their 
biology and co-morbidities. We hypothesised that GAD but not PD symptoms at 15 are 
associated with depression diagnosis at 18. 
Methods: Using longitudinal data from the ALSPAC birth cohort we examined relations of 
GAD and PD symptoms (measured by DAWBA) at 15 to depression at 18 (by CIS-R) using 
logistic regression. We excluded adolescents already depressed at 15 and adjusted for social 
class, maternal education, birth order, gender, alcohol intake and smoking. We repeated these 
analyses following multiple imputation for missing data. 
Results: In the sample with complete data (n=2835), high and moderate GAD symptoms in 
adolescents not depressed at 15, were associated with increased risk of depression at 18 both 
in unadjusted analyses and adjusting for PD symptoms at 15 and the above potential 
confounders. The adjusted OR for depression at 18 in adolescents with high relative to low 
GAD scores was 5.2 [95% C.I. 3.0 - 9.1; overall p<0.0001]. There were no associations 
between PD symptoms and depression at 18 in any model (high relative to low PD scores, 
adjusted OR= 1.3 [95% C.I. 0.3 - 4.8], overall p=0.737). Missing data imputation 
strengthened the relations of GAD symptoms with depression (high relative to low GAD 
scores, OR= 6.2, [95% C.I. 3.9 - 9.9]) but those for PD became weaker. 
Conclusion: Symptoms of GAD but not PD at 15 are associated with depression at 18. 
Clinicians should be aware that adolescents with GAD symptoms may develop depression. 
 
Key Words: Depression, Anxiety, Generalised Anxiety Disorder, Adolescent, ALSPAC 
4 
 
INTRODUCTION 
 
Depression is a leading cause of morbidity with a high cost to society (Sobocki et al. 2006). 
The incidence of depression increases rapidly during late adolescence. For example in the 
Dunedin study (Jaffee et al. 2002) the prevalence rose from 4% at age 15 to 16% at age 18, 
while in the National Comorbidity Survey adolescent supplement the prevalence of major 
depression or dysthymia rose from 8.7% at age 13-14 to 15.7% at age 17-18 (Merikangas et 
al. 2010). Depression with onset during adolescence carries a high risk of relapse, for 
example in one study in the United States, 40% of 16 year olds with depression experienced a 
relapse by the age of 23 (Lewinsohn et al. l999). In addition, adolescence is an important 
period for the acquisition of education and development of social and interpersonal skills and 
a period of depression may disrupt these formative processes with adverse consequences for 
an individual’s future. Understanding the underlying risk factors for depression is therefore 
important, especially where such risk factors could be identified and modified.  
 
The presence of an anxiety disorder is one such risk factor for the development of depression 
(Wittchen et al. 2004, Kessler et al, 1998). Comorbidity of anxiety disorders and depression 
is common (Kessler et al. 1996, Wittchen et al. 2003, Kessler et al. 2005). (Kessler et al. 
1996) using data from the original US National Comorbidity Survey, illustrated that the 
majority of cases of depression are secondary to another psychiatric diagnosis, with the 
primary disorder most commonly being an anxiety disorder. Anxiety disorders are often 
chronic in their course and frequently have onset in childhood or adolescence (Asselmann & 
Beesdo-Baum, 2015). The general consensus from longitudinal studies in adolescents and in 
adults is that anxiety disorders precede depression more frequently than vice versa (Pine et al. 
1998, Stein et al. 2001, Goodwin et al. 2002, Merikangas et al. 2003, Bittner et al. 2004).  
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However diagnostic manuals (World Health Organization 1993, American Psychiatric 
Association 1994) suggest there are several distinct anxiety disorders. While most (e.g. social 
phobia, specific phobia, agoraphobia and post traumatic stress disorder) must be linked to 
well-defined exposures, for generalised anxiety disorder (GAD) and panic disorder this is not 
the case. The cardinal symptom of GAD is chronic worry whereas a diagnosis of panic 
disorder requires the experience of recurrent panic attacks. GAD and panic disorder have 
distinct biology (Wilkinson et al. 1998), medical co-morbidities (Davies et al. 2012, Davies 
& Allgulander, 2013) and differ in the frequency of reports of genetic association with 
depression (Roy et al. 1995, Kendler, 2001, Kendler et al. 2003a, Kendler et al. 2007). Factor 
analyses of cross-sectional data in large populations had suggested that GAD may be more 
closely associated with depression than is panic disorder (Krueger, 1999, Vollebergh et al.  
2001, Slade & Watson, 2006). Although this finding was confirmed in a population of 
adolescents and young adults (Beesdo-Baum et al. 2009) there remains a controversy over 
whether this factor structure is robust to addition of other diagnoses and in other age groups 
(Wittchen et al. 2009).  
 
An analysis from the National Comorbidity Survey Replication reported correlations of 0.62 
and 0.48 for twelve month prevalence of major depressive episode with GAD and panic 
disorder respectively in population-based adult sample. (Kessler et al. 2005). In a 
retrospective analysis of longitudinal data, in individuals who had met criteria for both GAD 
and major depressive episode, (Wittchen et al. 2003) the depression diagnosis followed that 
of GAD in 52% of individuals and preceded GAD in only 29%. In a further study which 
relied on participants’ recall in a population who had experienced depression and panic 
attacks, a first depressive episode was recalled as occurring after the first panic attack in 43% 
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of cases and preceding it in 31% (Kessler et al. 1998). However in a sub-sample who had had 
a diagnosis of panic disorder, which has a higher threshold, 22% recalled that panic disorder 
preceded the first depressive episode whereas 48% reported that a depressive episode began 
first. 
 
A limited number of longitudinal studies have attempted to investigate the risk that having an 
individual anxiety disorder or anxiety symptoms with onset in adolescence carries for 
subsequent development of depression. Some studies (Pine et al. 1998), having recruited 
individuals prior to adolescence and only examined anxiety disorder diagnoses specifically 
relevant to children, do not include disorders well recognised in adulthood such as GAD and 
panic disorder. However, a study of 2548 individuals aged 14-24, each followed up for 4 
years (Bittner et al. 2004), provides some indication that GAD may have a higher predictive 
value for depression than does panic disorder. In unadjusted analyses all five of the anxiety 
disorders examined at baseline in this study, including generalized anxiety disorder and panic 
disorder, conferred an elevated risk of first onset of major depressive disorder. However, after 
adjustment for prior co-morbid mental disorders, it appeared that panic disorder was no 
longer associated with subsequent depression. In contrast an association of GAD with 
depression remained following adjustment, although there was considerable uncertainty as to 
the magnitude of the relation as evidenced by the broad confidence intervals. Among 
individuals with GAD or agoraphobia at baseline, comorbid panic attacks did not increase the 
risk for major depression. It should be noted however that in this study there was 
considerable heterogeneity of ages with most of the sample being beyond adolescence even at 
entry (range 14-24 years).  When the link between panic attacks and depression was 
examined after ten years of follow up, panic at baseline did confer an elevated risk for a 
diagnosis of depression over this longer period (Asselman et al. 2014a).  
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A smaller study of 906 children aged 9-13 reported no relationship between GAD and 
subsequent depression at ages 13-19 (Bittner et al. 2007). The authors acknowledged that the 
predictive value of disorders may differ depending on the developmental stage. They 
postulated that the restrictive DSM-IV criteria for GAD in children and adolescents 
(American Psychiatric Association 1994) made it more difficult to demonstrate associations 
with other psychiatric disorders. In contrast, GAD’s diagnostic predecessor (overanxious 
disorder) did show an association with depression, as it had done in earlier studies (Pine et al. 
1998). To our knowledge no study has specifically examined the impact of GAD and panic 
disorder from a fixed point in adolescence on the prevalence of depression at the onset of 
adulthood when the rise in incidence of depression is steepest.  
 
While some evidence therefore suggests that GAD may be more closely associated with 
depression than is panic disorder, a single definitive mechanism that might underlie this link 
cannot be identified. Possible mechanisms which may contribute include: a) genetics, as 
evidenced by the overlaps between generalised anxiety disorder and depression discussed 
above. This might involve a genetic pleiotropy involving multiple polymorphisms 
predisposing to both depression and GAD simultaneously, one example being a 
polymorphism in the gene coding for the serotonin 5HT-1A receptor (Molina et al. 2011), 
although this has not been replicated in genome wide association studies, b) a common 
biological mechanism such as cortisol dysregulation which is known to be involved in the 
aetiology of depression. A recent paper examining evidence of HPA axis dysfunction across 
the anxiety disorders found evidence in GAD, but was inconclusive for panic disorder 
(Faravelli et al. 2012, Abelson et al. 2007), c) a vulnerability of GAD and depression, but not 
panic disorder to a specific but as yet unidentified risk factor (although a risk factor 
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answering this description was not identified in an earlier examination of risk factors for 
depression and individual anxiety disorders (Beesdo et al. 2010) d) a psychological effect of 
one disorder leading to the other (e.g. generalised anxiety causing demoralisation and leading 
to depression), or e) GAD but not panic disorder being an early developmental manifestation 
of depression. 
 
The Avon Longitudinal Study of Parents and Children (ALSPAC) (Golding et al. 2001) 
provides an opportunity to study factors contributing to increased risk of depression at 18 in a 
prospective cohort study design. In the present study we will consider symptoms of anxiety 
disorders in adolescence as risk factors for the subsequent development of depression by the 
age of 18, making the distinction between symptom patterns suggestive of GAD and panic 
disorder. Despite clear-cut differences in symptoms and diagnostic criteria, few studies have 
attempted to distinguish between the predictive ability of these two common forms of anxiety 
for the risk of future depression, which is important to know for detection of depression and 
potentially for prevention of its onset. Given the genetic associations between GAD and 
depression, and the suggestion of an association of these disorders at four years in an earlier 
longitudinal study, we hypothesised that GAD but not panic disorder symptoms at age 15 are 
associated with a diagnosis of depression at 18. Elucidating this relationship may have 
practical implications for prevention of depression.   
 
METHOD 
DATA SOURCE 
The sample comprised participants from the Avon Longitudinal Study of Parents and 
Children (ALSPAC). All pregnant women resident in the former Avon Health Authority in 
9 
 
south-west England having an estimated date of delivery between 1 April 1991 and 31 
December 1992 were invited to take part. The children of 15247 pregnancies were recruited.  
Compared with the 1991 National Census data of residents in Avon, ALSPAC had a slightly 
greater proportion of mothers who were married or cohabiting and who were owner-
occupiers but was similar for other demographic variables.  Ethical approval for the study 
was obtained from the ALSPAC Law and Ethics Committee and the Local Research Ethics 
Committees. More detailed information on the ALSPAC study is available on the study web 
site which contains details of all the data that is available through a fully searchable data 
dictionary (http://www.bris.ac.uk/alspac/researchers/data-access/data-dictionary/). Detailed 
information has been collected on the cohort since early pregnancy, including regular self-
reported information from mothers and children and face to face assessments in research 
clinics (Boyd et al. 2013). The current study uses data from the remaining sample of 
ALSPAC offspring who attended the two most recent research clinics for the children at age 
15 and 18.  
 
SAMPLE SIZE 
 Our starting sample was those with complete anxiety and depression data from the 
Development and Well-Being Assessment (DAWBA) (Goodman et al. 2000), the exposure 
variable, at age 15 (n=5365). Those in the highest of the six bands of symptoms for 
depression on the DAWBA (indicating a probable diagnosis of depression based on 
symptoms over the past 2 weeks) at 15 were removed from the sample at the outset (n= 89), 
including 40 out of 269 (15%) of those with highest levels of GAD and 4 out of 32 (13%) of 
those with highest levels of panic symptoms.)  Of the remaining sample, 3635 adolescents 
also had complete depression outcome data using the Clinical Interview Schedule – Revised 
(CIS-R) at age 18.  A final sample with complete data across all exposure, outcome and 
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confounding variables comprised 2835 participants. However, all missing data was imputed 
and all analyses described below were repeated using the same starting sample size (n=5365) 
in final sensitivity analyses.  
We imputed for missing data because missing data can bias results if the data are not missing 
completely at random.  Given that there is substantial information on socio-demographic 
variables in ALSPAC that predict missingness, missing information can be assumed 
dependent on observed data. Thus we employed a fully conditional specification as 
implemented in the Multivariate Imputation by Chained Equations (MICE) algorithm in 
STATA 12, using all variables described in the analyses and additional auxiliary variables 
predictive of incomplete variables and/or missingness (these included socio-demographic 
indicators and earlier continuous measures of depression; full list available on request) to 
predict missing data across 100 imputed datasets. The resulting Monte Carlo errors were less 
than 10% of the standard error and FMI values were no larger than 0.4, indicating that 100 
imputed datasets was sufficient. Analyses were conducted post imputation by combining 
estimates across imputed data sets using Rubin’s rules.  
MEASURES 
GAD and Panic at age 15. 
Symptoms of GAD, panic and depression were measured by the Development and Well-
Being Assessment (DAWBA) at the age of 15. We used the pencil and paper version of the 
DAWBA for self–completion.  The DAWBA consists of questions about child mental health 
symptoms and their impact. The questions for each disorder follow the diagnostic criteria 
operationalised in the Diagnostic and Statistical Manual of Mental Disorders, 4th edition 
[DSM-IV] (American Psychiatric Association 1994) or the International Classification of 
Diseases [ICD-10] Diagnostic Criteria for Research (World Health Organization 1993). 
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Accordingly questions on generalised anxiety disorder refer to the last six months and those 
on panic disorder to the last four weeks. Note that for GAD, DAWBA employs the diagnostic 
criteria F93.80 from ICD-10’s Diagnostic Criteria for Research, termed ‘Generalized Anxiety 
Disorder of Childhood’ which closely resembles the criteria for GAD in DSM-IV (category 
300.02) but differs markedly from ICD-10’s adult GAD criteria (F41.1) which require the 
presence of autonomic symptoms and/or dry mouth. Each section contains 20–25 questions. 
Ordered categorical variables from 1 to 6 or ‘bands’ for each ICD-10 or DSM-IV disorder are 
derived from symptoms using a computerised algorithm (Goodman et al. 2011). This 
approach has the advantage of describing the symptom intensity for disorders along a 
continuum which may be particularly helpful in adolescence, where some disorders are rare 
but the presence of symptoms which do not meet the threshold for diagnosis is much more 
common. The levels of symptoms for each “band” were chosen to provide an approximately 
evenly spaced progression in terms of the log odds of the child having the disorder in 
question (Goodman et al. 2011). Binary indicators of probable diagnosis are also generated. 
However, we used ordered-categorical measures in order to make full use of the symptom 
variation and to allow investigation of dose response effects.  Due to low frequency within 
some bands, we collapsed data from the original 6 levels to form 3 ordinal levels ranging 
from lowest to highest probability of having the disorder in question (i.e. low, medium and 
high symptom bands). In addition, continuous symptom scores for GAD and panic were 
derived from the sum of all symptom items within the relevant section of the DAWBA. These 
symptom scores were used as exposure variables in secondary analyses. 
 
Depression at age 18 (outcome variable) 
Depression at 18 years old was measured using the computerised version of the Clinical 
Interview Schedule-Revised (CIS-R). The CIS-R is a computerised interview that derives a 
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diagnosis of depression according to ICD-10 criteria (World Health Organization 1993), the 
timeframe being the past two weeks. The interview has been fully standardised and is equally 
reliable whether conducted by a lay or clinically trained interviewer or self administered on 
the computerised version (Lewis, 1994). The CIS-R is designed for, and has been widely 
used within, community samples including the National Surveys of Psychiatric Morbidity and 
the 1958 birth cohort.  A binary variable indicating presence versus absence of a diagnosis of 
depression was taken as the outcome measure. 
Confounding Variables 
Variables that are associated with both anxiety and depression in adolescence were selected. 
These included maternal education (Park et al. 2013, Chen & Li, 2009, Letourneau et al. 
2006), social class (using the Office of Population Censuses and Surveys ‘Standard 
Occupational Classification’ (OPCS 1995)), child gender, birth order (Gates et al. 1998), 
child smoking status (ever smoked a cigarette yes/no) and frequency of child alcohol use (6-
level ordinal variable from never to daily alcohol consumption). 
  
ANALYSES 
The exposure variable was DAWBA symptom bands at age 15 (3 level ordered categorical 
variable) and the outcome was diagnosis of depression at age 18 (binary variable). The 
associations between GAD and panic symptom bands and depression diagnosis were first 
investigated within separate logistic regression models using STATA 12 (StataCorp 2011).  
We then investigated the association with both these exposures in the same logistic regression 
model.  Confounding variables were then introduced into the models, including adjustments 
for depression symptoms at age 15 (ordered categorical variable, using DAWBA bands from 
1-5 with those in band 6 having been excluded). These analyses were repeated using 
13 
 
symptom scores for GAD and panic as continuous exposure variables.  Finally, the models 
described above were repeated following imputation for missing data. Population attributable 
fraction was calculated as (1-population unattributable fraction) using the ‘punaf’ command 
in STATA. This calculates the population unattributable fraction as the ratio of the log of 
scenario means for the outcome (depression at 18) in the baseline scenario vs the ‘ideal’ 
scenario in which the risk factor (here being medium or high anxiety at 15) is set to zero. 
 
RESULTS 
DESCRIPTIVE STATISTICS 
Sample demographics for the adolescents who comprised our complete case sample as 
compared with the rest of ALSPAC are given in table 1. As can be seen the adolescents with 
complete case data came from more socially advantaged families. 
Comorbidity 
Frequency of scoring within each of the DAWBA bands, comorbidity and symptom scores 
are given in table 2. As can be seen a large proportion of those with high levels of panic have 
high levels of GAD. 
Association between GAD and panic with confounding variables 
After removing those with co-morbid depression, those in higher GAD symptom bands at age 
15 were more likely to be girls (chi2 (2) = 182, p<0.001: 75% of adolescents in the highest 
band were girls), to drink alcohol more frequently (chi2(12) = 29 p<0.001) and to have ever 
smoked a cigarette (chi2(2)=14 p<0.001).  A similar pattern was seen for panic: those in 
higher panic symptom bands were more likely to be girls (chi2(2) = 27, p<0.001: 75% of 
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adolescents in the highest band were girls), to drink alcohol more frequently (chi2 (12) = 31 
p<0.001) and to have ever smoked a cigarette (chi2(2)=5 p<0.084, 68% of those in the top 
band compared to only 47% in lowest band had tried a cigarette). There was no association 
between either GAD or panic and maternal education, social class or parity.   
MAIN ANALYSES 
As can be seen in table 3, adolescents with medium and high levels of either GAD or panic 
symptoms at age 15 more frequently received a diagnosis of depression at 18. Univariate 
logistic regression models provide strong evidence for an association between GAD and 
depression (odds ratio for high GAD symptom band vs low GAD symptom band = 6.6 (95% 
C.I. 3.9 to 11.2)) and a trend towards an association between panic and depression at age 18 
(odds ratio for high panic symptom band vs low panic symptoms band = 3.1 (95% C.I. 0.9 to 
10.8)). The association of high GAD symptoms with depression was robust to the addition of 
panic (model 2) and to addition of the six confounding variables described above (model 3, 
odds ratio for high GAD symptom band vs low GAD symptom band = 5.2 (95% C.I. 3.0 to 
9.1)) as well as the addition of baseline depression (model 4, odds ratio for high GAD 
symptom band vs low GAD symptom band = 3.8 (95% C.I. 2.1 to 6.7)).  In contrast, the 
association with panic diminished markedly once GAD was included in the model (odds ratio 
for high panic symptom band vs low panic symptom band = 1.6 (95% C.I. 0.4 to 5.9)) and 
remained so after adjustment for the further confounders and baseline depression. This 
reflects the relatively large proportion of those with high panic symptom scores also having 
high GAD symptom scores (32%, see above). This pattern of results was also found when 
using the symptom scores as continuous exposure variables (row 5 in table 4). The 
association between GAD and depression was strengthened following imputation for missing 
data, whilst any association with panic was further weakened (see table 5). 
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The population attributable fraction (PAF) provides an index of the proportion of depression 
cases at 18 that could be prevented by removing moderate or high symptoms of GAD at 15 
(assuming a causal relationship). Based on the fully adjusted regression (model 4) described 
above the PAF is 0.37 (0.20 to 0.50), suggesting that if causal successfully eliminating 
moderate or high symptoms of GAD at 15 would prevent 37% of depressed cases at 18.  
 
DISCUSSION 
 
Our findings confirm our original hypotheses that symptoms of GAD but not panic disorder 
at age 15 are associated with depression at 18. Symptoms of GAD at 15 are strongly 
associated with subsequent depression, and this relationship remained after adjustment for 
confounders including baseline depressive symptoms and was strengthened further on 
missing data imputation. The elevated risk for depression at 18 applied even to those whose 
GAD symptoms at 15 were rated as moderate. However the apparent association between 
panic symptoms and later depression on the unadjusted analysis was a result of confounding 
by an association between panic and GAD. Overall, the present study strengthens the existing 
literature suggesting that depression is more closely associated with GAD than with panic 
disorder. It supports the broader concept that GAD and panic disorder differ in their co-
morbidities.  
 
We note that since lifetime incidence of depression prior to age 15 was not assessed these 
data do not allow us to say with certainty that GAD invariably precedes depression since it is 
conceivable that some participants had experienced depression earlier in their development 
which had remitted some time before their DAWBA assessment at age 15. However given 
the relatively low prevalence of depression at 15 we believe that such individuals are likely to 
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be few in number. Despite an earlier analysis failing to identify temperament, personality or 
environmental risk factors shared by GAD and depression but not other anxiety disorder 
(Beesdo et al. 2010), there remains the possibility that our results reflect a developmental 
phenomenon, in that the expression of GAD symptoms could represent an early manifestation 
of depression if the two symptom groups had common aetiology through shared genetic, 
biological or environmental factors, or were manifestations of the same disorder. In some 
individuals the brain at 15 may be more readily able to express anxiety, worry and the 
somatic symptoms of GAD than sadness, misery or the biological symptoms of depression 
despite the aetiology being the same. Thus development of GAD symptoms at 15 could be 
seen as evidence of an individual being on a trajectory due to common underlying causes 
which will result in depression at 18 unless adaptation occurs or treatment is instigated. 
However, some authors have argued that depression and GAD have sufficient differences in 
terms of risk factors, co-morbidities and treatment strategies that it is unrealistic to consider 
them as manifestations of a single underlying cause (Hettema 2008). As such it remains 
possible that the presence of generalized anxiety with pervasive worry causes demoralization 
which is more likely to lead to depression as a separate disorder, than is the more episodic 
phenomenon of panic attacks experienced in panic disorder.  
 
Whether or not GAD and depression are truly separate disorders (Mennin et al. 2008), our 
study suggests that late adolescence is a period where GAD symptoms are common and are 
linked to an increased prevalence of depression subsequently. It is important to recognise the 
developmental context: the period from age 15-18 is when the sharpest rise in the incidence 
of depression is observed, a disorder that has huge public health importance. Therefore it is 
possible that this period may provide an opportunity to identify and treat symptoms of GAD 
which is beneficial in itself and may have the added benefit of reducing the risk of a 
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subsequent depressive disorder occurring. Identification and treatment of panic disorder 
remains important as this disorder is unpleasant and disabling in its own right. The lack of 
any association between panic symptoms and subsequent depression contrasts with the 
reported co-morbidity of panic disorder and depression in the general population (Skapinakis 
et al. 2011) suggesting that these are separate disorders that may co-occur without having a 
developmental link. However, it remains possible that depression following on from panic 
merely takes longer to emerge as suggested by reports of an association after 10 years’ follow 
up (Asselmann et al. 2014a) but not after four years (Bittner et al. 2004). Indeed treatment of 
panic attacks in adolescents and young adults appeared to reduce the incidence of depression 
at the 10 year follow up timepoint (Asselmann et al. 2014b). 
 
GAD can be treated successfully, both by psychological therapies (Hunot et al. 2007) and by 
medications (Ravindran & Stein, 2010, Baldwin et al. 2014). While the evidence is more 
limited for some drug classes in children than is the case in adults, cognitive behavioural 
therapy is effective both in children and adolescents (Compton et al. 2004, Ishikawa et al. 
2007). We hypothesise that successful treatment of adolescents with GAD could have the 
additional beneficial effect of reducing the risk of developing depression and its many 
undesirable consequences. Such an intervention could be considered to be a form of indicated 
prevention (Mrazek & Haggerty 1994). The impact of such an indicated prevention would 
need to be evaluated and balanced against any possible risk of self harm (Olfson et al. 2003, 
Hammad 2004). 
 
We advocate better mechanisms for identifying adolescents who experience GAD, including 
its core symptom of chronic worry. It is known that recognition rates for anxiety disorders in 
primary care are suboptimal (Wittchen et al. 2002, Wittchen et al. 2012). Although 
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administration of screening instruments for anxiety disorders has been shown to feasible in 
adults (Wittchen et al. 2002) and children (Simon & Boegels 2009) it is unclear whether it 
could be justified in primary care populations. A systematic review examining the value of 
screening for depression in primary care using a routinely administered questionnaire 
concluded that the benefits were marginal (Gilbody et al. 2005) although it was 
acknowledged that a more sophisticated two stage procedure for screening and case finding 
had yet to be evaluated.  
 
The strengths of the study are the large sample size, that it is population-based, with both 
exposure and outcome data being collected from individuals at fixed ages, and the 
longitudinal design. Possible limitations include the attrition rates in ALSPAC reducing 
representativeness and applicability of the sample to the general population. This problem 
was addressed at least in part by use of imputation techniques for missing data. While as 
many as 46% of individuals had one or more missing data value, the benefits of imputation 
are that biases associated with exclusion of subjects who do not provide complete data are 
avoided. As there was little difference between imputed and non-imputed results, our 
confidence in our findings is increased.  The number of participants in the highest DAWBA 
symptom band for panic was small. The smaller number of participants in this symptom band 
reduces the power to find an association with depression at 18. The distribution of the panic 
symptom bands at 15 reflects the fact that the panic disorder diagnosis is relatively rare at that 
age, but panic attacks are more common and our approach of using the DAWBA symptom 
bands as exposure variables rather than simply the presence or absence of a full clinical 
diagnosis mitigates the problem to some extent. Finally the DAWBA estimates likelihood of 
diagnosis of GAD based on DSM-IV and the ICD-10 diagnostic criteria for research category 
F93.80. In both cases these criteria include symptoms such as sleep disturbance and poor 
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concentration, which are also considered features of depression. Thus using the DAWBA 
may tend to increase the overlap of GAD and depression compared with any instrument 
which used ICD’s more autonomically oriented F41.1 criteria. 
 
Further studies are required to establish whether identifying and treating GAD in adolescents 
reduces either the incidence or the severity of subsequent depression.  
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Table 1: Sample demographics  
 ALSPAC sample lacking exposure data  
n=9613 
Exposure (DAWBA) data available  
n=5365 
Complete cases and depressed 
cases at 15 removed 
n=2835 
Female  6570 (45%) 2820 (53%) 1557 (55%) 
Maternal Education     
Up to 16 only 4808 (70%) 2501 (52%) 1347 (48%) 
                      Up to 18  1402 (20%) 1402 (29%) 889 (31%) 
University Degree 723 (10%) 887 (19%) 599 (21%) 
Social Class    
(highest )1 263 (5%) 334 (8%) 250 (9%) 
2 1604 (28%) 1581 (36%) 1066 (38%) 
3 3060 (53%) 2060 (47%) 1290 (46%) 
(lowest) 4 or 5 838 (14%) 385 (9%) 228 (8%) 
Mean (s.d.) Age of Mother 26.7 (5) 28.5 (5) 28.9 (4) 
First Born 4736 (58%)  2518 (51%)  1353 (48%) 
Never smoked (measured at No data available  2778 (51.8%)  1613 (56.9%) 
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age 15)  
Alcohol consumption  
Never 
Once/twice 
Used to drink but not now 
Sometimes but less than 
once a week 
1-2 times a week 
Drink more than twice a 
week 
Drink every day 
 
No data available  
754 (14.1%) 
604 (11.3 %) 
166 (3.1%) 
2666 (49.8 %) 
923 (17.2 %) 
207 (3.9 %) 
 
33 (0.6%) 
 
424 (14.9 %) 
330 (11.6%) 
79 (2.8 %) 
1458 (51.4%) 
441 (15.6 %) 
92 (3.2 %) 
 
12 (0.4%) 
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Table 2: Mean total GAD symptom score according to each DAWBA symptom intensity banda for GAD (upper panel) and Mean total panic symptom score 
according to each DAWBA symptom intensity banda for panic (lower panel) for the whole sample at age 15 excluding those depressed (n =5276). 
 
 
 
 
 
 
 
 
 
 
  
 
a GAD and panic symptom intensity measured by DAWBA and divided into low, medium and high symptom bands (see methods section) 
 Frequency Mean (s.d.) GAD symptom score Comorbidity (frequency and % in high 
panic symptom band) 
Low GAD 
symptom band  
n= 2096 (40%) 0.9 (0.8) 1 (0.1%) 
Medium GAD 
symptom band   
n=2951 (56%) 2.8 (1.6) 18 (0.6%) 
High GAD 
symptom band   
n=229 (4%) 17.8 (4.4) 
 
9 (4%) 
 Frequency Mean (s.d.) Panic symptom score  Comorbidity (frequency and % in high GAD 
symptom band) 
Low panic 
symptom band 
n=5140 (97%) 0.005 (0.2) 199 (0.04%) 
Medium panic 
symptom band   
n=108 (2%) 9.4 (3.1) 21 (19%) 
High panic 
symptom band   
n=28 (1%) 11.5 (3.3)  9 (32%) 
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Table 3: Frequencies of depressiona at 18 according to GAD and Panic symptom severityb at 15 by DAWBA symptom bands, for the non-depressed sample at 
15 (n=3635). 
 
 
 
 
 
 
 
adepression identified by CIS-R  
b GAD and panic symptom intensity measured by DAWBA and divided into low, medium and high symptom bands (see methods section) 
 
 Proportion (%) of those  in each symptom band at 15 
who go on to have depressiona at 18 
Low GAD symptom band  54/1433 (4%) 
Medium GAD symptom band   163/ 1876 (8%) 
High GAD symptom band   38/ 124 (23%) 
 Proportion (%) of those  in each symptom band at 15 
who go on to have depressiona at 18 
Low panic symptom band  240/3544 (7%) 
Medium panic symptom band   12/72 (17%) 
High panic symptom band   3/16 (17%) 
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Table 4: Odds ratio for depression at 18 according to according to GAD and Panic symptom severity at age 15 by DAWBA bands (compared to the lowest 
symptom band) and continuous symptom score for a) GAD and b) Panic  in separate logistic regression models, combined models and following 
adjustments  for confounding variables.  Models are for complete cases across all exposure, outcome and confounding variables with exclusion of those 
with depression at 15 (n= 2835).  
4a) O.R.s for depression at 18 with GAD symptom intensityb at 15 as exposure 
 
 
 Model 1  
OR for depressiona at 18 
(95% CI) (Unadjusted) 
 
Model 2  
OR for depressiona at 18 
(95% CI) (adjusted for 
panic) 
 
Model 3  
OR for depressiona at 
18 (adjusted for panicb 
and  confoundersc ) 
 
Model 4  
OR for depressiona at 18 
(adjusted for  panicb  and  
confoundersc   + depression 
symptom bandsd at 15) 
 
Low GAD symptom band 1 (reference category) 1 (reference category) 1 (reference category) 1 (reference category) 
Medium GAD symptom  band 1.9 (1.3 to 2.7) 1.9 (1.3 to 2.7) 1.7 (1.2 to 2.5) 1.5 (0.9 to 2.1) 
High GAD symptom band 6.6 (3.9 to 11.2) 6.3 (3.7 to 10.8) 5.2 (3.0 to 9.1) 3.8 (2.1 to 6.7) 
Overall effect  using likelihood ratio 
test 
P<0.0001 
 
P<0.0001 
 
P<0.0001 
 
P=0.0001 
 
Continuous GAD symptom score 
(Odds ratio reflects increased odds 
for a 1 standard deviation symptom 
increase) 
1.5 (1.4 to 1.7) p<0.001 1.5 (1.4 to 1.7) 
P<0.001 
1.5 (1.3 to 1.7) 
P<0.001 
1.4 (1.2 to 1.6) 
p<0.001 
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4b) O.R.s for depression at 18 with panic symptom intensityb at 15 as exposure 
 
 
a Depression identified by CIS-R 
b GAD, and panic symptom intensity at 15 measured by DAWBA and divided into low, medium and high symptom bands (see methods section) 
c  social class, maternal education, birth order, child gender, child smoking status (ever smoked a cigarette yes/no), child frequency of alcoholic drinks (6 
levels, I have never tried alcohol up to I drink every day) 
d depression symptom intensity at 15 measured by DAWBA, divided into bands 1-5 (as described in the methods section, those in band 6 at age 15 were 
excluded)  
 
 Model 1  
OR for depressiona at 18 
(95% CI) (Unadjusted) 
 
Model 2  
OR for depressiona at 18 
(95% CI) (adjusted for 
GAD) 
 
Model 3  
OR for depressiona at 
18 (adjusted for GADb 
and confoundersc) 
 
Model 4 
OR for depressiona at 18 
(adjusted for GADb and 
confoundersc + depression 
symptom bandsd  at 15) 
Low panic symptom band 1 (reference category) 1 (reference category) 1 (reference category) 1 (reference category) 
Medium panic symptom  band 2.1 (0.9 to 5.0) 1.4 (0.6 to 3.5) 1.4 (0.6 to 3.5) 1.3 (0.5 to 3.2) 
High panic symptom band 3.1 (0.9 to 10.8) 1.6 (0.4 to 5.9) 1.3 (0.3 to 4.8) 1.2 (0.3 to 4.5) 
Overall effect  using likelihood ratio 
test 
P=0.094 P=0.629 P=0.737 P= 0.838 
Continuous symptom score  
(Odds ratio reflects increased odds 
for a 1 standard deviation symptom 
increase) 
1.1 (1.0 to 1.1) 
p=0.006 
1.0 (1.0 to 1.0) 
P=0.530 
1.0 (1.0 to 1.0) 
P=0.744 
1.0 (1.0 to 1.0) 
P=0.790 
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Table 5: Main analyses model 3 before and after imputing missing data.  
 OR for depressiona at 18 (adjusted 
for panicb and confoundersc) 
complete cases as above  
(n= 2835). 
 
OR for depressiona at 18 (adjusted 
for panicb and confoundersc) after 
imputing for missing data 
(n=5276) 
Low GAD symptom bandb 1 (reference category) 1 (reference category) 
Medium GAD symptom  bandb 1.7 (1.2 to 2.5) 2.0 (1.5 to 2.7) 
High GAD symptom bandb 5.2 (3.0 to 9.1) 5.8 (3.7 to 9.2) 
Continuous GAD symptom score  
(Odds ratio reflects increased odds for a 1 
symptom increase) 
1.3 (1.2 to 1.4) 
P<0.001 
1.3 (1.2 to 1.4) 
P<0.001 
 OR for depressiona at 18 (adjusted 
for GADb and confoundersc) 
complete cases as above 
(n= 2835). 
 
OR for depressiona at 18 (adjusted 
for GADb and confoundersc) after 
imputing for missing data 
(n=5276) 
Low panic symptom bandb 1 (reference category) 1 (reference category) 
Medium panic symptom  bandb 1.4 (0.6 to 3.5) 1.5 (0.8 to 2.8) 
High panic symptom bandb 1.3 (0.3 to 4.8) 1.1 (0.3 to 4.1) 
Continuous GAD symptom score  
(Odds ratio reflects increased odds for a 1 
symptom increase) 
1.0 (0.9 to 1.1) 
P=0.760 
1.0 (0.9 to 1.0) 
P=0.402 
 
a Depression identified by CIS-R 
b GAD and panic symptom intensity at 15 measured by DAWBA and divided into low, medium and high symptom bands (see methods section) 
c social class, maternal education, birth order, child gender, child smoking status (ever smoked a cigarette yes/no), child frequency of alcoholic drinks (6 
levels, I have never tried alcohol up to I drink every day). 
